Literature DB >> 26296810

Prognostic Value of Quantitative Diffusion-Weighted MRI in Patients with Traumatic Brain Injury.

Afaaf Shakir1, Didem Aksoy2, Michael Mlynash3, Odette A Harris4, Gregory W Albers5, Karen G Hirsch6.   

Abstract

BACKGROUND AND
PURPOSE: Data about the predictive value of quantitative diffusion-weighted MRI in traumatic brain injury (TBI) patients is lacking. This study aimed to determine if specific apparent diffusion coefficient (ADC) thresholds could be determined that correlate with outcome in moderate-severe TBI.
METHODS: This retrospective observational study investigated patients with moderate-severe TBI. MRIs obtained post-injury days 1-13 were analyzed. MRIs were obtained on a 1.5T scanner; 20-23 contiguous diffusion-weighted imaging (DWI) sections with a spin-echo echo planar imaging DWI 256×256 reconstructed matrix; field of view 24×24 cm; slice thickness/gap of 5/1.5 or 5/2.5 mm. The ADC value of each brain tissue voxel was determined. The percentage of voxels below different ADC thresholds was calculated and correlated with outcome. A good outcome was defined as discharge to home or a rehabilitation facility.
RESULTS: Seventy-six patients were analyzed. Thirty-five patients (46%) had a good outcome. The timing of MRI scans did not differ between groups, but the mean age did (42±18 years vs. 56±19 years, p<.01, good vs. poor outcome). Patients with poor outcome had significantly higher percentage of brain volume with ADC < 400×10(-6) mm2 /second (.85±.67% vs. .60±.29%, poor vs. good outcome, p<.05). Using a ROC curve analysis and Youden's index, an ADC <400×10(-6) mm2 /second in ≥.49% of brain was 85% sensitive and 46% specific for poor outcome (p<.05).
CONCLUSIONS: Quantitative MRI offers additional prognostic information in acute TBI. A whole brain tissue ADC threshold of <400×10(-6) mm2 /second in ≥.49% of brain may be a novel prognostic biomarker.
Copyright © 2015 by the American Society of Neuroimaging.

Entities:  

Keywords:  MRI; Traumatic brain injury; diffusion-weighted imaging; prognosis

Mesh:

Year:  2015        PMID: 26296810     DOI: 10.1111/jon.12286

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  6 in total

1.  Use of magnetic resonance imaging in severe pediatric traumatic brain injury: assessment of current practice.

Authors:  Peter A Ferrazzano; Bedda L Rosario; Stephen R Wisniewski; Nadeem I Shafi; Heather M Siefkes; Darryl K Miles; Andrew L Alexander; Michael J Bell
Journal:  J Neurosurg Pediatr       Date:  2019-02-08       Impact factor: 2.375

2.  Diffusion-weighted imaging of injuries to the visual centers of the brain in patients with type 2 diabetes and retinopathy.

Authors:  Ming Liang; Xing Chen; Feng Xue; Lingna Meng; Yunfeng Cong
Journal:  Exp Ther Med       Date:  2017-06-12       Impact factor: 2.447

3.  Brain Tissue Damage Induced by Multimodal Neuromonitoring In Situ during MRI after Severe Traumatic Brain Injury: Incidence and Clinical Relevance.

Authors:  Daniel Pinggera; Paul Rhomberg; Ronny Beer; Claudius Thomé; Ondra Petr
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

4.  Lesions in deep gray nuclei after severe traumatic brain injury predict neurologic outcome.

Authors:  Frédéric Clarençon; Éric Bardinet; Jacques Martinerie; Vincent Pelbarg; Nicolas Menjot de Champfleur; Rajiv Gupta; Eléonore Tollard; Gustavo Soto-Ares; Danielle Ibarrola; Emmanuelle Schmitt; Thomas Tourdias; Vincent Degos; Jérome Yelnik; Didier Dormont; Louis Puybasset; Damien Galanaud
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 5.  Clinical applications of diffusion-weighted sequence in brain imaging: beyond stroke.

Authors:  Siddhartha Gaddamanugu; Omid Shafaat; Houman Sotoudeh; Amir Hossein Sarrami; Ali Rezaei; Zahra Saadatpour; Aparna Singhal
Journal:  Neuroradiology       Date:  2021-10-01       Impact factor: 2.804

6.  Imaging findings and outcomes after traumatic cerebellar injury: a canine case report.

Authors:  Masamichi Yamashita; Yusuke Murahata; Inoru Yokoe; Yoshiharu Okamoto; Tomohiro Imagawa
Journal:  BMC Vet Res       Date:  2022-03-31       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.